XML 40 R32.htm IDEA: XBRL DOCUMENT

Segment Information (Tables)

12 Months Ended

Dec. 31, 2012

The following is a summary of certain financial data for each of the Company’s business segments:


	Year Ended December 31, 2012		Year Ended December 31, 2011
Net Sales
Pharmaceutical	$	59,409	$	0
Nutraceutical		725,909		0

Total		785,318		0

Operating Loss
Pharmaceutical		8,293,821		7,417,917
Nutraceutical		95,993		0

Total		8,389,814		7,417,917

Identifiable Assets
Pharmaceutical		7,167,478		7,503,229
Nutraceutical		641,400		0

Total	$	7,808,878	$	7,503,229

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details